Ferring wins Nocdurna patent suit with ex-employee

25-08-2020

Rory O'Neill

Ferring wins Nocdurna patent suit with ex-employee

Oleschwander / Shutterstock.com

Swiss-based Ferring Pharmaceuticals has prevailed in a patent dispute with rivals Serenity Pharmaceuticals and Reprise Biopharmaceuticals over a nighttime urination, or nocturia, treatment.


Ferring, Serenity, Reprise, Nocdurna, desmopressin, FDA, nocturia, patents, invalidation, inventor

LSIPR